Literature DB >> 500134

An immunogenetic basis for the tissue involvement in Behçet's syndrome.

T Lehner, J R Batchelor, S J Challacombe, L Kennedy.   

Abstract

The multifocal involvement in Behçet's syndrome was grouped into a spectrum of four types, three of which appeared to have an immunogenetic basis. HLA-B5 was related to the ocular type of Behçet's syndrome (relative risk 7.3), HLA-B27 to the arthritic type (relative risk 12.1) and HLA-B12 to the muco-cutaneous type (relative risk 3.9). The concept that recurrent oral ulceration and Behçet's syndrome may belong to a disease spectrum is substantiated by the natural course of the disease. Furthermore, patients with recurrent oral ulcers share with the muco-cutaneous type of Behçet's syndrome a significantly increased frequency of HLA-B12 (relative risk 2.6). The HLA markers may also prove to be significant in the differential diagnosis and prognosis of a disease which may present under a confusing variety of clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500134      PMCID: PMC1457127     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Polyarthritis in Behcet's multiple symptom complex.

Authors:  R W STRACHAN; F W WIGZELL
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

2.  Recurrent aphthous ulceration of the mouth; a study of the natural history, aetiology, and treatment.

Authors:  W SIRCUS; R CHURCH; J KELLEHER
Journal:  Q J Med       Date:  1957-04

3.  [Aphthosis: recent data and review].

Authors:  A TOURAINE
Journal:  Presse Med       Date:  1955-11-05       Impact factor: 1.228

Review 4.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

5.  Stimulation of lymphocyte transformation by tissue homogenates in recurrent oral ulceration.

Authors:  T Lehner
Journal:  Immunology       Date:  1967-08       Impact factor: 7.397

6.  A genetic study of Behçet disease in Israel.

Authors:  C Brautbar; T Chajek; S Ben-Tuvia; L Lamm; T Cohen
Journal:  Tissue Antigens       Date:  1978-02

7.  Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.

Authors:  T Sasazuki; Y Kohno; I Iwamoto; M Tanimura; S Naito
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

8.  Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.

Authors:  R J Levinsky; T Lehner
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

9.  The high prevalence of HLA-B5 in Behçet's disease.

Authors:  H Yazici; G Akokan; B Yalçin; A Müftüoğlu
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

10.  Behcet's syndrome in 32 patients in Yorkshire.

Authors:  M A Chamberlain
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

View more
  13 in total

1.  Cryoglobulins in Behçet's syndrome and recurrent oral ulceration: assay by laser nephelometry.

Authors:  T Lehner; A Losito; D G Williams
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

2.  Immunohistology of oral lesions from patients with recurrent oral ulcers and Behçet's syndrome.

Authors:  L W Poulter; T Lehner
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

4.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

5.  Lymphocyte abnormalities in Behçet's syndrome.

Authors:  A M Denman; P J Fialkow; B K Pelton; A C Salo; D J Appleford; C Gilchrist
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

6.  Behçet's syndrome.

Authors:  C G Barnes
Journal:  J R Soc Med       Date:  1984-10       Impact factor: 5.344

7.  Enhancement of granulocyte chemotaxis in Behcet's disease.

Authors:  D Djawari; O P Hornstein; J Schötz
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

8.  Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and Behçet's syndrome.

Authors:  T Lehner; M Adinolfi
Journal:  J Clin Pathol       Date:  1980-03       Impact factor: 3.411

9.  The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.

Authors:  T Lehner; K I Welsh; J R Batchelor
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

10.  Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.

Authors:  M Stanford; T Whittall; L A Bergmeier; M Lindblad; S Lundin; T Shinnick; Y Mizushima; J Holmgren; T Lehner
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.